These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 32242089)

  • 21. COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know.
    Dhawan R; Gundry RL; Brett-Major DM; Mahr C; Thiele GM; Lindsey ML; Anderson DR
    J Mol Cell Cardiol; 2020 Jul; 144():12-14. PubMed ID: 32339565
    [No Abstract]   [Full Text] [Related]  

  • 22. The interplay of hypertension, ACE-2 and SARS-CoV-2: Emerging data as the "Ariadne's thread" for the "labyrinth" of COVID-19.
    Tsioufis C; Dimitriadis K; Tousoulis D
    Hellenic J Cardiol; 2020; 61(1):31-33. PubMed ID: 32450334
    [No Abstract]   [Full Text] [Related]  

  • 23. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.
    Delpino MV; Quarleri J
    Front Cell Infect Microbiol; 2020; 10():340. PubMed ID: 32596170
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiovascular disease and the impact of COVID-19.
    Yoganathan A; Sajjad MS; Harky A
    J Card Surg; 2020 Aug; 35(8):2113. PubMed ID: 32542799
    [No Abstract]   [Full Text] [Related]  

  • 25. SARS-CoV-2 perturbs the renin-angiotensin system and energy metabolism.
    Mori J; Oudit GY; Lopaschuk GD
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E43-E47. PubMed ID: 32469255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proposed mechanism for increased COVID-19 mortality in patients with decompensated cirrhosis.
    Grace JA; Casey S; Burrell LM; Angus PW
    Hepatol Int; 2020 Sep; 14(5):884-885. PubMed ID: 32886332
    [No Abstract]   [Full Text] [Related]  

  • 27. COVID-19 and obesity: links and risks.
    Lavie CJ; Sanchis-Gomar F; Henry BM; Lippi G
    Expert Rev Endocrinol Metab; 2020 Jul; 15(4):215-216. PubMed ID: 32441223
    [No Abstract]   [Full Text] [Related]  

  • 28. Androgen-driven COVID-19 infection - is testosterone an enemy or a friend?
    Grubić Kezele T
    Horm Mol Biol Clin Investig; 2020 Jun; 41(2):. PubMed ID: 32598310
    [No Abstract]   [Full Text] [Related]  

  • 29. Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication.
    Pang X; Cui Y; Zhu Y
    Acta Pharmacol Sin; 2020 Sep; 41(9):1255-1257. PubMed ID: 32581256
    [No Abstract]   [Full Text] [Related]  

  • 30. COVID-19 - Does This Disease Kill Due to Imbalance of the Renin Angiotensin System (RAS) Caused by Genetic and Gender Differences in the Response to Viral ACE 2 Attack?
    Arnold RH
    Heart Lung Circ; 2020 Jul; 29(7):964-972. PubMed ID: 32564908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic Syndrome and COVID 19: Endocrine-Immune-Vascular Interactions Shapes Clinical Course.
    Bansal R; Gubbi S; Muniyappa R
    Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32603424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [ACE2 and coronavirus - a question of balance and dynamics?].
    Lundström A; Sandén P
    Lakartidningen; 2020 Apr; 117():. PubMed ID: 32314329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 and the kidney.
    Hassanein M; Radhakrishnan Y; Sedor J; Vachharajani T; Vachharajani VT; Augustine J; Demirjian S; Thomas G
    Cleve Clin J Med; 2020 Oct; 87(10):619-631. PubMed ID: 33004323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic review of the role of renin-angiotensin system inhibitors in late studies on Covid-19: A new challenge overcome?
    Volpe M; Battistoni A
    Int J Cardiol; 2020 Dec; 321():150-154. PubMed ID: 32738257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19: gastrointestinal symptoms and potential sources of SARS-CoV-2 transmission.
    Kotfis K; Skonieczna-Żydecka K
    Anaesthesiol Intensive Ther; 2020; 52(2):171-172. PubMed ID: 32200613
    [No Abstract]   [Full Text] [Related]  

  • 36. SARS-CoV-2 & Covid-19: Key-Roles of the 'Renin-Angiotensin' System / Vitamin D Impacting Drug and Vaccine Developments.
    Cao Z; Wu Y; Faucon E; Sabatier JM
    Infect Disord Drug Targets; 2020; 20(3):348-349. PubMed ID: 32370727
    [No Abstract]   [Full Text] [Related]  

  • 37. Renin-Angiotensin-Aldosterone System Inhibitors Impact on COVID-19 Mortality: What's Next for ACE2?
    Patel AB; Verma A
    Clin Infect Dis; 2020 Nov; 71(16):2129-2131. PubMed ID: 32442259
    [No Abstract]   [Full Text] [Related]  

  • 38. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct SARS-CoV-2 infection of the heart potentiates the cardiovascular sequelae of COVID-19.
    Bose RJC; McCarthy JR
    Drug Discov Today; 2020 Sep; 25(9):1559-1560. PubMed ID: 32592868
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence.
    Turgeon RD; Zieroth S; Bewick D; Chow CM; Clarke B; Cowan S; Fordyce CB; Fournier A; Gin K; Gupta A; Hardiman S; Jackson S; Lau B; Leong-Poi H; Mansour S; Marelli A; Quraishi AR; Roifman I; Ruel M; Sapp J; Singh G; Small G; Virani S; Wood DA; Krahn A
    Can J Cardiol; 2020 Aug; 36(8):1180-1182. PubMed ID: 32502522
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.